Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
103 (48%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-06-25 | 2020-08-21 | 118909 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-11-06 | 2020-11-12 | 128019 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2022-12-22 | 2023-04-28 | 179297 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2020-09-24 | 2020-10-08 | 124989 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Actual shortage | 2025-05-02 | 2025-05-02 | 256450 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-02-18 | 2021-03-04 | 134337 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2017-08-02 | 2018-01-03 | 17987 |
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2017-08-21 | 2018-05-11 | 19984 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2023-06-16 | 2023-06-27 | 195201 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2024-08-08 | 2024-11-01 | 234882 |
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2017-08-21 | 2018-01-04 | 19981 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2017-08-02 | 2018-01-03 | 17994 |
| TEVA-RAMIPRIL | 5MG | CAPSULE | Actual shortage | 2025-03-13 | 2025-04-24 | 252578 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Actual shortage | 2025-03-13 | 2025-05-08 | 252581 |
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2023-04-27 | 2023-06-21 | 190686 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-10-07 | 2021-11-11 | 146853 |
| TEVA-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2017-05-10 | 2018-01-03 | 9802 |
| TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2017-08-02 | 2018-01-04 | 17997 |
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2019-10-24 | 2020-02-13 | 97156 |
| TEVA-RAMIPRIL | 5MG | CAPSULE | Resolved | 2022-04-21 | 2022-08-20 | 159210 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |